SEO Support Can We Slow Parkinson's? Prasinezumab and the Race to Target Alpha-Synuclein Every approved Parkinson's medicine today treats symptoms. None has been proven to slow the disease itself. That's why the progress of prasinezumab — an antibody designed to target the misfolded prote... Medication Parkinson's Research Nov 6, 2026
SEO Support Stem Cell Therapy for Parkinson's: Japan's World-First Approval and the Trials Behind It For decades, replacing the dopamine-producing brain cells lost in Parkinson's disease has been the field's most ambitious goal. In 2026 it moved from laboratory promise to regulatory reality: Japan gr... Parkinson's Research Treatments & Technology Nov 3, 2026
SEO Support Solengepras: A Non-Dopamine Parkinson's Pill Succeeds in Phase 3 Almost every Parkinson's medicine in use today works by boosting dopamine — replacing it (levodopa), mimicking it (dopamine agonists), or slowing its breakdown (MAO-B and COMT inhibitors). On 7 Octobe... Medication Parkinson's Research Oct 20, 2026
SEO Support Tavapadon (Juvmo) Approved: What the First D1/D5 Parkinson's Pill Means for Patients In late September 2026, the US Food and Drug Administration approved tavapadon, which AbbVie will sell under the brand name Juvmo, for adults with Parkinson's disease. It is a once-daily pill, and it ... Medication Parkinson's Research Oct 17, 2026
SEO Support Parkinson's Disease in India: Earlier Onset, the Care Gap, and World Parkinson's Day 2026 World Parkinson's Day falls on April 11 every year, marking the birthday of Dr. James Parkinson, who first clinically described the condition in 1817. The 2026 global theme, "Bridge the Care Gap," cou... Parkinson's Research Parkinson's in India Oct 15, 2026
SEO Support Blood and Skin Biomarker Tests: The New Frontier in Earlier Parkinson's Diagnosis For over 200 years, Parkinson's disease has been diagnosed the same way: a clinician watches how a person moves, checking for tremor, stiffness, and slowness, because there has been no simple lab test... Early Diagnosis Parkinson's Research Aug 8, 2026
SEO Support FDA-Approved Adaptive Deep Brain Stimulation: How "Smart" DBS Is Changing Parkinson's Care For thirty years, deep brain stimulation (DBS) has helped people with advanced Parkinson's disease regain motor control when medication alone stops working well. In February 2025, that technology took... Parkinson's Research Treatments & Technology Aug 4, 2026
SEO Support Mucuna Pruriens for Parkinson's: Research, L-Dopa Benefits & Treatment Mucuna Pruriens for Parkinson's Disease: What the Research Actually Says For centuries, Ayurvedic medicine has used Mucuna Pruriens (Velvet Bean) to treat "Kampavata," a condition mirroring Parkinson'... Ayurveda & Herbs Parkinson's Research May 11, 2026
